A. Menarini Manufacturing Logistics and Services S.r.l. (manufacturing "in bulk", packaging, batch release, batch control)

The drug is indicated for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria. It is also indicated for children aged 6 to 11 years weighing at least 20 kg.

Dosage form: tablets, dispersible in the oral cavity

ATC: R06AX29